Immediate Impact
1 by Nobel laureates 2 from Science/Nature 55 standout
Citing Papers
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
2023 Standout
Prostate cancer
2021 Standout
Works of Mohamed Darif being referenced
Results of the phase II TRAXAR study: A randomized phase II trial of axitinib and TRC105 (TRAX) versus axitinib (AX) alone in patients with advanced or metastatic renal cell carcinoma (mRCC)
2019
Relationship of time to metastasis (TTM) and site of metastases in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): Results from the phase 3 SPARTAN trial.
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mohamed Darif | 475 | 319 | 288 | 28 | 794 | |
| M. Hoffmann | 504 | 125 | 206 | 19 | 653 | |
| Marilena Bellò | 330 | 193 | 302 | 29 | 870 | |
| John H. Barton | 344 | 92 | 520 | 32 | 875 | |
| Kazushige Tsutsui | 265 | 88 | 186 | 31 | 843 | |
| Eve Gallop‐Evans | 579 | 114 | 358 | 27 | 845 | |
| Niels Murawski | 697 | 123 | 474 | 38 | 936 | |
| J M Connors | 553 | 55 | 390 | 16 | 935 | |
| Patrizia Albertini | 566 | 45 | 257 | 17 | 699 | |
| Viola Poeschel | 680 | 118 | 444 | 38 | 833 | |
| Elaine K. Wong | 264 | 63 | 561 | 19 | 910 |
All Works
Loading papers...